Gufic Biosciences Limited — Board Meeting, 14-08-2026: Outcome of Board Meeting

Gufic Biosciences' board approved Q1 results, posting a consolidated net profit of ₹22.31 Cr on revenues of ₹260.82 Cr. The company also decided to incorporate a new subsidiary in the Philippines with an investment of up to USD 250,000 to boost its presence and sales in the region.